All Conditions & Treatments

Lupus, Osteoporosis and Bone Health

Adapted from a presentation to the SLE Workshop at Hospital for Special Surgery

A young woman getting a DEXA bone scan.

People with lupus have a greater-than-average risk of developing osteoporosis. This article explains the relationship between lupus, bone health and osteoporosis, as well as ways to mitigate your own risks and manage osteoporosis. Please visit our main condition page for a complete overview of lupus.

What is osteoporosis?

Osteoporosis is a disease characterized by low bone mass and/or micro-architectural deterioration of bone tissue leading to bone fragility and increased risk of fractures/broken bones. Bones are compromised in quantity, quality, or a combination of both.

Osteoporosis is common

  • 54 million Americans have low bone mass and osteoporosis
  • 1 in 2 women and 1 in 4 men will break a bone in their lifetime due to osteoporosis

The risk of osteoporosis and fractures increases with age. However, younger patients with diseases, conditions, medical procedures and medications that has a negative impact on the skeleton may also suffer with low bone density and fractures.

Poor bone quality and low bone density increases the risk of fragility fractures. These are fractures that occur as the result of a fall from standing height or less or no identifiable trauma; an injury that would be insufficient to fracture/break a normal bone

What is the normal bone growth cycle?

Bone is living tissue. Even as adults we are constantly remodeling our entire skeleton. In the normal bone growth cycle, our bodies continually:

  • make new bone, although less so as we age (bone formation)
  • remove older, fatigued bone (bone resorption)
  • maintain a resting bone state when the cycle of new bone growth and old bone removal are in balance (bone homeostasis)

Bone remodeling is the body’s way of breaking down weak bone and rebuilding stronger bone. Both genders acquire up to 90% of their adult bone by age twenty. After age 30, our bodies remove bone mass faster than it can be built. This bone loss accelerates in women in the first five years after menopause (defined as the last menstrual period).

Osteoporosis has thus been described as a pediatric disease with adult consequences. Optimization of our genetically predetermined peak bone mass during this critical period of skeletal growth is critical to prevent or delay the development of low bone mass and osteoporosis as we age.

What can cause bone loss in people with lupus?

Inflammation is only one of several factors contributing to bone loss in people with lupus. Others include:

  • The use of corticosteroids or glucocorticoids. These drugs are often used to treat lupus and can also lead to bone loss, because they decrease the body’s ability to absorb calcium, and they break down the minerals in bones.
  • Kidney disease, which affects about 30% of people with lupus.
  • Diminished ability or desire to engage in physical activity because of severe lupus symptoms. (Physical activity increases bone strength.)
  • Being postmenopausal, going through early menopause, or having no menstrual periods, because estrogen is a bone-protective hormone.
  • A family history of osteoporosis.
  • Insufficient intake of important vitamins and minerals.
  • Tobacco or nicotine use (smoking, vaping, chew, snuff, and nicotine gums or patches)
  • Excessive drinking of alcohol.

A condition called avascular necrosis (also known as osteonecrosis) occurs in about 10% of lupus patients and is related to steroid use. This usually occurs in the hip joints. The condition is characterized by reduced blood supply to the bone along with increased swelling and pressure. Bone weakens, causing tiny cracks, which lead to joint pain, decreased movement within the joint, and muscle spasm. At the end stage, the bone collapses under stress.

Why do people with lupus have a greater chance of getting osteoporosis?

Chronic inflammation associated with lupus and medications used to treat the disease – particularly prednisone and other corticosteroid drugs (“steroids”) – all contribute to the risk. Bone removal occurs at an increased rate with certain diseases, such as lupus. The body tries to replace bone that was removed, but as we age or when we are coping with lupus, this process slows down. This imbalance between bone formation and bone resorption leads to bone loss.

In addition, inadequate intake or absorption of bone-building calcium and Vitamin D, and less exercise due to fatigue and pain from lupus, may contribute to a reduction in bone mineralization and progressive bone loss. Many people with lupus are advised to avoid sun exposure, because ultraviolet (UV) light can trigger disease flares in some of these individuals. UV light stimulates the production of Vitamin D in our bodies, an important substance for bone health. Although sun exposure creates only a limited amount of Vitamin D, even so, with lower sun exposure, many people with lupus will be low on Vitamin D and thus at greater risk for developing osteoporosis.

What are the unchangeable risk factors of osteoporosis for people with lupus?

Osteoporosis risk factors individuals have no control over include:

  • race/gender/age: Caucasian and Asian postmenopausal women over the age of 65; men over the age of 70
  • small, thin frame
  • family history of osteoporosis and/or hip fracture
  • diabetes
  • hyperthyroidism (Grave’s disease)
  • rheumatoid arthritis
  • lupus
  • renal (kidney) disease
  • malabsorption disorders (in which a person's body does not correctly absorb nutrients such as carbohydrates, proteins, fats, vitamins or minerals), for example:
    • celiac disease
    • irritable bowel disease
    • complications or side effects of bariatric surgery
  • congenital (since birth) bone and collagen disease

How can people with lupus prevent osteoporosis?

The good news is that we can do things to make bones healthier, stimulate bone formation and slow down bone resorption. For people with lupus, the main treatment approach emphasizes controlling inflammation and preventing organ damage. There are additional approaches to reduce the risk of developing osteoporosis. These include:

  • Exercising: In particular, weight-bearing, muscle-building exercises (to augment aerobic exercise).
  • Following good nutrition and caloric intake guidelines, and supplementing with vitamins and minerals, if needed, to address:
    • Eating disorders, low body weight or obesity
    • Inadequate calcium and vitamin D intake
    • Gastrointestinal issues such as celiac disease, which inhibit calcium absorption
  • Reducing caffeine intake.
  • Avoiding smoking.
  • Moderating alcohol consumption – no more than two to three drinks per day.
  • Making medication changes:
    • Avoid long-term use of prednisone and other corticosteroids when possible. A bone-preserving treatment goal would be to take the lowest dose of steroids for the shortest period of time possible to control disease activity. Studies show that even doses as low as 2.5 mg to 7.5 mg daily for extended periods increase a person’s risk of fracture.
    • The use of immunosuppressive drug therapy to taper steroid use, when medically feasible to control disease activity, can help to preserve bone.
    • Be aware that other medications can have effects on bone health, and consult your doctor if you take any of these:
      • proton pump inhibitors
      • anticonvulsants
      • antidepressants
      • aromatase inhibitors
      • thyroid hormones in excess

Tips on exercise and good nutrition


Age-related loss of skeletal muscle mass is common, and with it comes diminished function. This may take place in tandem with increased body fat. Low muscle mass translates to low muscle strength. Both weight-bearing and resistance exercises are helpful.

  • weight-bearing exercises
    • goal of 15 to 60 minutes two to three times per week
    • standing and moving against gravity
    • examples: high- and low-impact aerobics, walking, jogging, t’ai chi, yoga, Pilates (the latter three are also good for balance, strength, and fall prevention)
  • resistance exercises
    • muscle-strengthening through moving the body against gravity (can include using light weights, resistance bands)
    • non-impact exercises improve balance, posture, function

Good nutrition

Calcium and vitamin D are key: The preferred approach now favors obtaining calcium through eating a healthy, well-balanced diet, and adding supplements if needed to make up any shortfall.

Good calcium-rich food sources include:

  • dairy – low-fat milk, yogurt, cheese and other dairy products
  • green leafy vegetables – broccoli, kale, collard greens, Swiss chard, bok choy
  • seafood – salmon, sardines and tuna
  • other – fortified juices, cereals, breads, soy products, almond milk, almonds

Below are daily requirements of calcium and vitamin D3 – from both diet (food sources) and dietary supplements, measured in international units (IU) and micrograms (mcg).

Age 50 and younger
1,000 mg calcium
400 to 800 international units (IU) of vitamin D3

Age 51 and older
1,200 mg calcium
800 to 1000 IU of vitamin D3

Age 70 and younger
1,000 mg calcium
400 to 800 international units (IU) of vitamin D3

Age 71 and older
1,200 mg calcium
800 to 1000 IU of vitamin D3

Calcium is best absorbed when taken in amounts of 500 mg to 600 mg or less at one time, preferably with a meal. Calcium citrate is most easily absorbed and can be taken with or without food. Calcium carbonate is another form of calcium that is more readily available when taken with meals. Calcium is available in liquid, tablet or chewable form. Side effects of calcium consumption can include constipation and kidney stones. Calcium supplements may have interactions with certain medications. In particular, calcium supplements should not be taken within two hours of taking a proton pump inhibitor, such as omeprazole (Prilosec), lansoprazole (Prevacid), famotidine (Pepcid), pantoprazole (Protonix), rabeprazole (Aciphex), dexlansoprazole (Dexilant), esomeprazole (Nexium), etc.

It tends to be difficult to receive enough vitamin D through natural means (exposure to sunlight and food), and so taking supplements may be recommended. Recommendations for vitamin D intake for both men and women are 600 IU (15 mcg) for those under age 70, and 800 IU (20 mcg) for older adults. It is a good idea to have your doctor check your vitamin D level with annual blood tests.

Vitamin D comes in two forms: cholecalciferol (D3), and ergocalciferol (D2). D3 is more easily metabolized. Good sources of vitamin D-rich foods include:

  • tuna, mackerel, salmon
  • egg yolks
  • certain fortified products, including orange juice, soy milk and cereal

How is bone quality evaluated?

Since osteoporosis is a silent disease and is not associated with pain until a bone is fractured, it is important to have screening tests to look at the quality or mineralization of the bone. Such screening tests include:

  • Dual-energy X-ray absorptiometry (DEXA or DXA) is a low-dose ionizing radiation X-ray used to measure bone mineral content. Postmenopausal women are encouraged to have a bone density exam every two years as are men age 70 or older. Earlier age is recommended with risk factors or low energy fractures.
  • Trabecular bone score (TBS), obtained through DEXA imaging, is a diagnostic tool that measures bone architecture and fracture risk.
  • Quantitative CT scan measures the volume of bone mineral density in the spine. This is another radiology test that can be performed if you have had a CT scan of your lumbar spine. The test looks at the inside quality of the bone in a few, specific vertebral bones in your spine.
  • Fracture Risk Assessment Tool (FRAX) score: Developed by the World Health Organization (WHO), this estimates a person’s 10-year risk of sustaining an overall major fracture and a hip fracture based on personal history and other risk factors.
  • Vertebral Fracture Assessment (VFA): This imaging study looks for hidden, painless fractures in the spine.
  • Laboratory testing: Blood and urine tests are methods to examine the amount of essential bone-building minerals in the body, in addition to identifying the effects of other disease processes on the bone. Testing can measure bone markers, which tell us how much bone your body is making at a certain point in time along with how much bone breakdown is occurring.

How are osteoporosis and osteopenia treated?

Like lupus, osteoporosis is a chronic disease with no cure. Once one is diagnosed with osteoporosis or osteopenia, taking calcium alone is not adequate to restore bone density. And while conservative measures such as diet and exercise can be beneficial for bone health, your physician might suggest a medication to prevent further bone loss. Fortunately, several medications are available for the prevention and treatment of osteoporosis. The decision to undertake treatment is a shared one between you and your doctor. It is important to discuss with your healthcare provider the indications, efficacy, pros and cons of various medications, in addition to any other concerns you might have.

Medical treatment targets various stages in the bone growth cycle, from bone formation to bone resorption. Most medications are designed to slow down bone resorption, and they are called antiresorptives.

Medications that decrease bone breakdown include:

  • oral bisphosphonates
    • alendronate (Fosamax)
    • risedronate (Actonel)
    • ibandronate (Boniva)
  • IV bisphosphonates
    • zoledronic acid (Reclast, Zometa): yearly infusion
  • rank-L inhibitor
    • denosumab (Prolia): subcutaneous injection every 6 months

Hormones that decrease bone breakdown include:

  • selective estrogen receptor modulators (SERMS): used within 10 years of menopause
    • raloxifene (Evista)
  • hormone replacement therapy (HRT): used during menopause
    • estrogen
    • progesterone
  • testosterone therapy
    • androgen

Anabolic medications improve the formation of new bone. These are given for a minimum of three months and a maximum of two years per lifetime via a daily injection with a pen injection device. Such medications include:

  • parathyroid hormone (PTH) and parathyroid-related protein (PTHrp)
    • teriparitide (Forteo) – PTH
    • abaloparitide (Tymlos) – PTHrp

One medication both decreases bone breakdown and increases bone growth. This drug is an antisclerostin monoclonal antibody that was approved by the Food and Drug Administration in 2019 for postmenopausal women at high risk for fracture. It is given by a subcutaneous injection every month for 12 months.

  • romosozumab (Evenity)

How can I avoid injury if I have osteoporosis?

The most important thing to do if you have osteoporosis is to avoid falling. Falls become more common as people advance in age. Many osteoporosis-related fractures are due to falls, and over 90% of hip fractures are due to falls. More than 33% of adults age 65 will experience a fall in a given year, while over 40% of those over 75 will fall. Falls can be reduced through:

  • visual and hearing screening and treatment
  • optimizing medications
  • avoiding throw rugs
  • reducing clutter, especially power cords on floors
  • installing handrails in key areas
  • optimizing bathroom lighting
  • installing bathtub safety bars and seats
  • wearing hip protectors

Loss of bone mineral density occurs naturally with the normal aging process. Lupus and its treatment with corticosteroids can increase an individual’s chance of developing a low bone mineral state such as osteopenia or osteoporosis. Screening tests to identify poor bone mineralization are important along with treatment with medications, if indicated. Conservative measures such as diet, supplements, exercises and fall prevention are all important to include in a bone-healthy lifestyle.

*Original presentation held January 30, 2020 by Patricia Donohue, ACNP, MPH, ONP, CCD, then the nurse practitioner for the HSS Osteoporosis and Metabolic Bone Health Center. Learn more about the SLE Workshop and get more information on support services at HSS available for people with lupus and their loved ones by visiting LupusLine®, LANtern® (Lupus Asian Network), and Charla de Lupus (Lupus Chat)®.


Alana C. Serota, MD, CCFP, CCD
Physician, Ambulatory Care Center, Hospital for Special Surgery
Physician, HSS Osteoporosis and Metabolic Bone Health Center

Related articles

References and resources

(Return to top.)

Success Stories


In-person and virtual appointments

Related Content